11.11.2021 • NewsBASFSolenis

Sale of Solenis to Platinum Equity Closes

With the receipt of all approvals, BASF and Clayton, Dubilier & Rice (CD&R) have closed the sale of water treatment company Solenis to Platinum Equity. The transfer to the new private equity investor for an enterprise value of $5.25 billion includes net debt of around $2.5 billion.

The buyer and sellers announced the deal this past July. At the time of sale, BASF held 49% of the two-year-old company, the investment group 51%, together with Solenis’ management.

The ownership structure emerged from CD&R’s $1.8 billion purchase of the water chemicals unit of US chemical producer Ashland in 2018. In 2019, the German group folded its water chemicals business into the new business.

BASF said the divestment of its shares in Solenis will be reflected in its financial reporting for the current fourth quarter as net income from shareholdings.

With more than 5,200 employees, Solenis produces mainly specialty chemicals used in water treatment and paper manufacturing. It also makes products for other water-intensive industries including chemical processing, mining and oil production. The Wilmington, Delaware-based US company reported sales of $ 3billion for fiscal year 2021 (Sept. 30).

Author: Dede Williams, Freelance Journalist

With receipt of all approvals, BASF and Clayton, Dubilier & Rice have closed...
With receipt of all approvals, BASF and Clayton, Dubilier & Rice have closed the sale of water treatment company Solenis to Platinum Equity. The transfer to the new private equity investor for an enterprise value of $5.25 million includes net debt of around $2.5 billion. (c) Solenis

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.